Mark Wentland

Mark Wentland, PhD, Medicinal Chemistry Advisor. Dr. Wentland is Professor Emeritus at Rensselaer Polytechnic Institute. Prior to his tenure at Rensselaer, Dr. Wentlland conducted drug discovery research at Sterling Winthrop and his last position was Sterling Winthrop Fellow and Oncology Discovery Co-Chairman. Dr. Wentland has led efforts resulting in the discovery of nine drug candidates, six of which have been advanced to clinical trials.